148289 - GLP-1RAs: Rethinking Treatment Intensification in People with T2D
- : Online
Optimising glycaemic management is a critical part of patient care, however the glycaemic target will vary depending on an individual patient’s risk versus benefit analysis and their personal priorities and health status.
This 1hr Category 2 activity, will review how glycaemic targets should be tailored and considered according to patient capabilities and the risk of severe hypoglycaemia, addresses factors that contribute to clinical inertia and considers the options of introducing GLP-1RAs to intensify treatment for people with T2D. This activity will also discuss the safety and efficacy of GLP-1RAs in optimising T2D treatment and on-going management.
The prevalence of type 2 diabetes (T2D) is increasing in Australia, most likely a result of rising overweight and obesity rates, lifestyle and dietary changes and an ageing population. According to self-reported data, in 2014-15 an estimated one million Australian adults had T2D. Approximately 25% of people over the age of 65 years have diabetes and 50% of older people have prediabetes.Learning outcomes